BioCentury
ARTICLE | Clinical News

Epogam and Efamast regulatory update

January 17, 2000 8:00 AM UTC

SOH said that the U.K.'s Committee on Safety of Medicines will review the company's Epogam and Efamast, which restore levels of gamma linoleic acid metabolites to treat atopic eczema and breast pain,...